Le-Vel Brands, LLC, has presented the National Breast Cancer Foundation (NBCF) with a donation from the proceeds of its limited-edition NBCF Derma Fusion Technology (DFT) DUO, of which $5 from every purchase in October was earmarked for the NBCF. This is the third consecutive year that Le-Vel has partnered with NBCF to promote breast cancer awareness; the company has donated more than $730,000 in total to NBCF during the last three years.
Founded in 1991 by breast cancer survivor Janelle Hail, NBCF maintains a steadfast mission to provide help and inspire hope to those affected by breast cancer through early detection, education and support services. The organization has received the highest rating of four stars by Charity Navigator, America’s largest independent charity evaluator, for 12 years.
Breast cancer is the most common cancer among women worldwide, but thanks to better screening and early detection, along with increased awareness and continually improving treatment options, death rates from breast cancer have been declining since about 1990. Since its inception, NBCF has been dedicated to providing help and inspiring hope to those affected by breast cancer through early detection, education and support services.
“Since 2015, Le-Vel has helped NBCF provide thousands of mammograms and patient navigation services for women in need. The donations have also allowed us to provide breast health education and early detection services in communities across America. We could not do this without partners like Le-Vel,” says Janelle Hail, Founder and CEO of NBCF.
According to NBCF statistics, one in eight women in the United States will be diagnosed with breast cancer in her lifetime, making the disease the most commonly diagnosed cancer in women. Breast cancer is the second-leading cause of cancer death among women. Each year, it is estimated that more than 252,710 women in the United States will be diagnosed with breast cancer, and more than 40,500 will die. On average, every two minutes, a woman is diagnosed with breast cancer, and one woman will die of breast cancer every 13 minutes.
Despite these alarming numbers, there is hope. More than 3.3 million breast cancer survivors are alive in the United States today – and that’s largely due to early detection and education. NBCF provides free mammograms to women in all 50 states through its network of hospitals, and offers other free services all aimed at empowering women to take control of their health.
“The National Breast Cancer Foundation works tirelessly on behalf of women’s health. At Le-Vel, we share that passion. We’re absolutely dedicated to doing whatever we can to champion the cause and encourage women everywhere to educate and empower themselves,” says Le-Vel Co-CEO, Co-Founder and Co-Owner Paul Gravette.
Le-Vel’s Derma Fusion Technology, or DFT, is part of a simple three-step regimen called THRIVE, designed to help people of all ages live healthier, more active, fuller lives. The first of its kind, the DFT time-released delivery system infuses the skin, or derma, with Le-Vel’s unique THRIVE Lifestyle Formula. Used in tandem with THRIVE Premium Lifestyle Shake and THRIVE Premium Lifestyle Capsules, THRIVE helps people recapture their well-being and reach peak physical and mental levels through weight management, digestive support, healthy joint function and lean muscle support, among other benefits. DFT DUO is the company’s first product focusing primarily on weight management and includes a dual application, enhanced formula concentration with significantly greater absorption. In conjunction with NBCF DFT DUO, Le-Vel’s #thrive4pink campaign in October supports its efforts to promote breast cancer awareness.
“This is a disease that affects everyone – individuals and families – and it’s touched many of our Brand Promoters and customers directly. The more we can support the National Breast Cancer Foundation in its efforts to spread the word, provide support and better educate people about breast cancer, the more lives we can impact or even help save,” says Le-Vel Co-CEO, Co-Founder and Co-Owner Jason Camper. “Le-Vel is deeply honored to champion the NBCF’s continued efforts to find a cure, and we look forward to the day when every breast cancer story has a happy ending.”
